Patricia de Jesus
Neurology · Caguas, PRNPI 1639379266
Payments from drug & device makers
Across 959 payments — averaging $323.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biogen$121K
- EMD Serono, Inc.$64K
- Genentech USA, Inc.$36K
- TG Therapeutics, Inc.$27K
- Bristol Myers Squibb$23K
- Sanofi$18K
- plus $20K from 18 others
What the payments were for
- Consulting fees$50,78516%
- Speaking & faculty fees$222,83372%
- Travel & lodging$9,9063%
- Food & beverage$26,4989%
- Education$1780%
- Gifts$600%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biogen | 252 | $120,937 |
| EMD Serono, Inc. | 108 | $64,431 |
| Genentech USA, Inc. | 77 | $35,666 |
| TG Therapeutics, Inc. | 27 | $27,390 |
| Bristol Myers Squibb | 26 | $23,405 |
| Sanofi | 58 | $18,117 |
| Novartis | 175 | $12,778 |
| E.r. Squibb & Sons, L.L.C. | 76 | $1,935 |
| AstraZeneca | 27 | $1,265 |
| Amgen(2 entities) | 20 | $1,105 |
| AbbVie(2 entities) | 20 | $603 |
| Johnson & Johnson | 24 | $569 |
| Genentech, Inc. | 6 | $456 |
| Banner Life Sciences, LLC | 20 | $444 |
| ANI Pharmaceuticals, Inc. | 9 | $243 |
| Teva Pharmaceuticals USA, Inc. | 9 | $202 |
| Mallinckrodt Enterprises LLC | 7 | $172 |
| Eli Lilly Export S.A. Puerto Rico Branch | 7 | $171 |
| UCB, Inc. | 3 | $167 |
| Chiesi USA, Inc. | 2 | $75 |
| Sanofi-aventis U.S. LLC | 3 | $63 |
| Viiv Healthcare Company | 1 | $29 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
| Mallinckrodt Hospital Products Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$310,260 in reported general payments places this provider in the 95th percentile of 129 neurology providers in Puerto Rico.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Kesimpta PenOfatumumab | 215 | $1,970,541 |
| VumerityDiroximel Fumarate | 67 | $580,057 |
| TecfideraDimethyl Fumarate | 58 | $541,471 |
| AubagioTeriflunomide | 53 | $494,020 |
| GilenyaFingolimod Hcl | 37 | $389,848 |
| ZeposiaOzanimod Hydrochloride | 41 | $363,857 |
| AmpyraDalfampridine | 83 | $361,189 |
| Avonex Pen (4 Pack)Interferon Beta-1a | 35 | $291,689 |
| EnspryngSatralizumab-Mwge | 13 | $222,396 |
| MayzentSiponimod | 20 | $194,195 |
| TysabriNatalizumab | 17 | $140,872 |
| CopaxoneGlatiramer Acetate | 11 | $79,124 |
| Emgality PenGalcanezumab-Gnlm | 82 | $59,744 |
| Dalfampridine ErDalfampridine | 327 | $55,108 |
| Glatiramer Acetate | 15 | $38,483 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| BiogenVumerity, Tecfidera, Tysabri | $120,937 | $1,262,400142 claims |
| NovartisGilenya, Mayzent | $12,778 | $584,04257 claims |
| SanofiAubagio | $18,117 | $494,02053 claims |
| E.r. Squibb & Sons, L.L.C.Zeposia | $1,935 | $363,85741 claims |
| Genentech USA, Inc.Enspryng | $35,666 | $222,39613 claims |
| Teva Pharmaceuticals USA, Inc.Copaxone | $202 | $79,12411 claims |
| AbbVieUbrelvy | $603 | $27,13020 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 129 neurology providers in Puerto Rico.
Other neurology in Caguas
- Jose Avila OrnelasCaguas$857K
- Karen Nater PineiroCaguas$7K
- Luis ForastieriCaguas$6K
- Naggai Gonzalez SegarraCaguas$4K
- Daniel Reyes de JesusCaguas$3K
- Ulises NoboCaguas$2K
- Angel ChineaGuaynabo$13.3M
- Diana BalsalobreGuaynabo$2.5M
- Ivonne Fraga BerriosHato Rey$1.7M
- Franchesca Fiorito-TorresSan Juan$489K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.